Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$4.27 - $8.26 $426,999 - $826,000
-100,000 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$7.07 - $11.62 $710,485 - $1.17 Million
-100,493 Reduced 50.12%
100,000 $802,000
Q3 2021

Nov 15, 2021

BUY
$9.94 - $12.77 $1.99 Million - $2.56 Million
200,493 New
200,493 $2.24 Million

Others Institutions Holding SLGC

About SomaLogic, Inc.


  • Ticker SLGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 183,452,992
  • Description
  • SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex prot...
More about SLGC
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.